Overview of Phage Immunoprecipitation Sequencing (PhIP-Seq) & Its Impact

Introduction Types Applications Biopanning Process Commercial Libraries

Phage display technology has enabled scientists to discover and enhance therapeutic peptides and proteins through advanced drug discovery methods. During the last twenty years phage display peptide libraries have become essential tools for both drug development and cancer screening. This article explains the scientific principles of phage display peptide libraries while exploring their multiple uses and benefits in life science research.

Why Use Phage Display Peptide Libraries?

Phage display peptide libraries lead drug development and peptide research with unmatched capabilities. This technology enables the rapid screening of large peptide collections to identify specific binding partners for target proteins and therapeutic peptides, accelerating the process far beyond the limitations of traditional methods.

Advantages in Drug Discovery and Peptide Identification

High-throughput screening: One experiment using phage display can quickly screen billions of peptides to find matching drug compounds more efficiently.
Target-specific binding: Phage display enables the selection of peptides that specifically bind to target molecules, thereby facilitating the development of novel therapeutic agents.
Cost-effective and efficient: Phage display libraries are both cost-effective and time-efficient, enabling the identification of peptide candidates for drug development at a reduced cost and in a shorter time frame.

Types of Phage Display Peptide Libraries

Phage display peptide libraries are divided into groups based on their construction and the diversity of peptides they contain.

Random Peptide Libraries

Researchers generate random peptide libraries that contain diverse peptide sequences. Random peptide sequencing enables the search of many different types of peptides which helps find effective binders. The process of making and using random peptide libraries helps screen for different types of peptides.

Randomization: Scientists create random peptide libraries by adding synthetic oligonucleotides that contain random peptide information to bacteriophage genomes, resulting in a library of phages displaying a wide variety of peptides.
Screening process: The libraries undergo biopanning to identify peptides that show strong binding to the target.

Phage clones binding selectivity evaluation by cell-ELISA. Fig. 1 Evaluation by cell-ELISA of the binding selectivity of twenty phage clones.¹

Combinatorial Peptide Libraries

Combining different random peptide sequences produces an expanded library of distinct variants through combinatorial peptide technology. These libraries are particularly useful for identifying exact peptide binding partners with high specificity and affinity.

Greater variability: Combining multiple peptide domains within single sequences boosts the library's diversity to help researchers find exact binding peptides.
Application in drug discovery: These libraries show outstanding results when researchers aim to find peptides that attach to distinct protein biomarkers including receptors.

Linear vs Cyclic Peptide Libraries

Peptides can be classified into linear and cyclic structures, each offering unique advantages and challenges.

Linear peptides: Scientists find it easy to make and adjust linear peptides yet these structures have poor resistance against enzymes that break down proteins quickly.
Cyclic peptides: Cyclic peptides maintain their shape through a stable loop structure that improves their stability and protects them from breakdown when put into the body.

Table 1. Advantages of Linear Peptides and Cyclic Peptides

Property	Linear Peptides	Cyclic Peptides
Stability	Less stable, prone to degradation	More stable, resistant to proteolysis
Synthesis	Easier and cheaper to synthesize	More complex synthesis process
Bioavailability	Often lower due to rapid degradation	Higher due to better stability
Applications	Less suitable for in vivo use	Ideal for therapeutic and diagnostic applications

Applications of Phage Display Peptide Libraries

Drug Discovery and Therapeutics

Targeting diseases with peptide-based drugs and drug delivery systems: Phage display peptide libraries help researchers identify specific drug delivery peptides. These libraries help identify peptides that specifically target disease sites, thereby enhancing drug targeting and reducing side effects on healthy tissues.
Peptides used in radiotherapy and immunotherapy: Researchers employ phage display technology to develop tumor-targeting peptides that boost the accuracy and performance of cancer radiotherapy and immunotherapy.

Biomarker Discovery

Phage display peptide libraries help find new biomarkers for medical tests and disease tracking. The discovery of biomarker-specific peptides enhances our ability to detect diseases early and provides better information about cancer development.

Cancer Diagnostics

Researchers use peptides from phage display libraries to develop better cancer diagnostic imaging methods. The peptides connect to specific proteins found in cancer tissue so doctors can create better and gentler imaging tools to detect tumors.

Protein-Protein Interactions

The use of phage display peptide libraries proves effective for examining how proteins connect with each other. When researchers find peptides that stick to target proteins, they create better ways to see how proteins work with each other in cells.

Biopanning Process for Phage Display Peptide Libraries

Phage display peptide libraries undergo biopanning to identify peptides that bind to their target. The method helps us select peptides that strongly connect with our target of interest.

Fig. 2 Competitive inhibition of binding of the positive phage to cells by the synthetic peptide.²

What is Biopanning?

Researchers put their phage display library through biopanning steps to test its binding with target molecules. The phages that stick to the target protein during biopanning remain captured while other phages are removed.

Steps in Biopanning

Immobilization: Reseachers attach target molecules to a solid surface for testing.
Incubation: The phage display library is incubated with the immobilized target molecule.
Washing: The phages that fail to bind are discarded during the washing process.
Elution and Amplification: Phages that bind to the target are eluted and then used to infect bacterial cells, which will produce more copies of the bound phages.
Repeat: The researchers can repeat the experiment to find more high-affinity binding peptides.

Commercial Phage Display Peptide Libraries

The availability of premade and custom phage display peptide libraries enables researchers to select from available options or create personalized libraries according to their project requirements.

Premade Peptide Libraries

Business companies sell ready-made libraries with millions of different peptide sequences to help with drug discovery research as well as medical testing and disease diagnosis. Creative Biolabs assembled numerous premade peptide libraries including linear and constrained types over recent years. It is worth mentioning that we offer two high-quality linear peptide libraries (16-mer and 20-mer), which are developed using the same authentic phage system as the NEB Ph.D. peptide libraries. We also provide a cyclic 9-mer peptide library, constructed using the same technical route.

Customization and Tailored Peptide Libraries

For specific research needs, custom phage display peptide libraries can be created. These libraries are designed to target particular proteins, cells, or diseases, offering tailored solutions for drug discovery and biomarker identification. Creative Biolabs has pioneered a technology for constructing constrained peptide libraries, enabling the creation of constrained peptides with target-specific cross-links. This approach involves the generation of natural or semi-synthetic peptides with constrained structures, enhancing their properties such as stability, protease resistance, protein binding affinity, and intrinsic cell permeability.

Conclusion

Phage display peptide libraries continue to face challenges, such as the instability of short linear peptides in vivo. Researchers are addressing this by modifying peptides to enhance their stability. Recent improvements in peptide library engineering have produced better-stable peptide structures to address existing difficulties.

Phage display peptide libraries show promising prospects as research continues to develop new therapeutic options and better peptide identification methods. Peptide development today aims to create exact medications that target particular disease markers especially for individualized cancer treatments. Combining phage display with other molecular display methods, such as yeast and ribosome display, will further enhance the diversity and specificity of peptide libraries.

References

Tu, Xiangan, et al. "Screening and identification of a renal carcinoma specific peptide from a phage display peptide library." Journal of Experimental & Clinical Cancer Research 30 (2011): 1-6. Under Open Access license CC BY 2.0, without modification.
Tang, Bo, et al. "Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library." PloS one 8.1 (2013): e54264. Under Open Access license CC BY 4.0, without modification.

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

	USA: Europe: Germany:
	Call us at: USA: UK: Germany:
	Fax:
	Email: